Venture capital firms used to moan that business angels were unprofessional and hard to work with. But Europe's new breed of angel investor networks appears anything but that, says Mary Lisbeth D'Amico
The annual growth of biotech cultivation grew last year at its slowest pace since 1996, when biotech crops were first commercialised, according to a report by the International Service for the Acquisition of Agri-Biotech Applications, a non-profit group that advocates the use of bio-crops.
Researchers at the Advanced Technology Institute at the University of Surrey recently reported that they have shown and observed a phenomenon called negative differential resistance - holding out the prospect of a new generation of cheap and fast semiconductors.
Micromet AG, a spin-off from the Institute for Immunology at Munich University, said it has agreed to grant four licenses of its single chain antibody technology to Abbott Laboratories, Alligator Bioscience AB, Haptogen Ltd. and an unnamed biopharmaceutical company, for the development of cancer treatments.
Lipoxen Plc, a drug spin-out company from the University of London's School of Pharmacy, said it has raised £3.78 million from a placing of 28 million shares for hiring news staff for preclinical trials to treat diabetes, Pneumococcal infections, and hepatitis C.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.